-36.2%
PDD vs GSK
+26.4%
-62.6%
-46.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.0% | -2.7% | -0.3% | -2.6% |
| 7D | -4.1% | -4.2% | +0.1% | -3.5% |
| 30D | -13.1% | -7.5% | -5.6% | -12.1% |
| 3M | -3.5% | -3.3% | -0.2% | -3.2% |
| 6M | -21.8% | -9.3% | -12.5% | -20.6% |
| YTD | -29.7% | +1.6% | -31.3% | -30.0% |
| 1Y | -36.2% | +25.5% | -61.7% | -38.3% |
| All | -36.2% | +26.4% | -62.6% | -38.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling